Yingying Du

2.6k total citations
91 papers, 1.2k citations indexed

About

Yingying Du is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingying Du has authored 91 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 25 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingying Du's work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Wheat and Barley Genetics and Pathology (8 papers). Yingying Du is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Wheat and Barley Genetics and Pathology (8 papers). Yingying Du collaborates with scholars based in China, United States and Australia. Yingying Du's co-authors include Duan Ma, Yating Chen, Yin‐Gang Hu, Lu Yang, Huijun Wang, Yifeng Lin, Jin Zhang, Yueyin Pan, Liang Chen and Anthony G. Condon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yingying Du

83 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingying Du China 19 443 358 263 151 149 91 1.2k
Ye Yuan United States 24 859 1.9× 154 0.4× 41 0.2× 64 0.4× 93 0.6× 95 1.6k
Lu Ma China 16 325 0.7× 52 0.1× 124 0.5× 87 0.6× 56 0.4× 63 1.0k
Wei Ma China 20 585 1.3× 280 0.8× 93 0.4× 13 0.1× 70 0.5× 80 1.2k
Changhong Zhu China 23 785 1.8× 206 0.6× 37 0.1× 27 0.2× 148 1.0× 72 1.9k
Rong Wei China 18 416 0.9× 124 0.3× 97 0.4× 108 0.7× 124 0.8× 61 1.2k
Yuanhua Liu China 26 790 1.8× 211 0.6× 57 0.2× 15 0.1× 131 0.9× 87 1.7k
Bolan Yu China 24 501 1.1× 110 0.3× 47 0.2× 18 0.1× 116 0.8× 60 1.4k
Jianbo Li China 20 597 1.3× 270 0.8× 96 0.4× 8 0.1× 114 0.8× 90 1.7k
Xiuhong Zhang China 18 657 1.5× 300 0.8× 29 0.1× 24 0.2× 123 0.8× 73 1.4k

Countries citing papers authored by Yingying Du

Since Specialization
Citations

This map shows the geographic impact of Yingying Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingying Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingying Du more than expected).

Fields of papers citing papers by Yingying Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingying Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingying Du. The network helps show where Yingying Du may publish in the future.

Co-authorship network of co-authors of Yingying Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yingying Du. A scholar is included among the top collaborators of Yingying Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingying Du. Yingying Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Beibei, Yangyang Dai, Zixin Wang, et al.. (2025). TET3 is a common epigenetic immunomodulator of pathogenic macrophages. Journal of Clinical Investigation. 135(21). 2 indexed citations
2.
Chen, Hui, Shijing Gong, Yingying Du, et al.. (2025). NRF2‐REGγ‐ACADM/KLF15 Signaling Pathway Regulates the Browning of White Adipose Tissue to Modulate Obesity. Advanced Science. 12(46). e09429–e09429.
3.
4.
Li, Kun, Bo Yang, Yingying Du, et al.. (2024). The HOXC10/NOD1/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer. Bone Research. 12(1). 47–47.
5.
Du, Yingying, Yan Liu, Tong Liu, et al.. (2024). The in vitro Activity of Omadacycline Alone and in Combination Against Carbapenem-Resistant Klebsiella pneumoniae. Infection and Drug Resistance. Volume 17. 5785–5794. 2 indexed citations
6.
7.
Du, Yingying, et al.. (2023). Identification of autophagy-related genes and immune cell infiltration characteristics in sepsis via bioinformatic analysis. Journal of Thoracic Disease. 15(4). 1770–1784. 11 indexed citations
8.
Zhou, Qing, Lin Wu, Bo Jiang, et al.. (2023). Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker.. Journal of Clinical Oncology. 41(16_suppl). 2570–2570. 4 indexed citations
9.
Liu, Sha, Wentao Xu, Ying Dai, et al.. (2023). Associations of circulating immunomarkers with the efficacy of immunotherapy for primary hepatic carcinoma. Cancer Medicine. 12(24). 21830–21848. 8 indexed citations
10.
11.
Du, Yingying, et al.. (2022). The Genomic Characterization of KPC-Producing Klebsiella pneumoniae from the ICU of a Teaching Hospital in Shanghai, China. SHILAP Revista de lepidopterología. 3 indexed citations
12.
13.
14.
Zhao, Xianlan, Yingying Du, Lei Zhao, et al.. (2018). The application of uterine wall local resection and reconstruction to preserve the uterus for the management of morbidly adherent placenta: Case series. Taiwanese Journal of Obstetrics and Gynecology. 57(2). 276–282. 13 indexed citations
15.
Xing, Na, et al.. (2015). Effects of low-flow sevoflurane anesthesia on renal function in low birth weight infants. BMC Anesthesiology. 15(1). 6–6. 4 indexed citations
16.
Xu, Xiaohan, Na Xing, Yingying Du, et al.. (2014). Tracheal rupture related to endotracheal intubation after thyroid surgery: a case report and systematic review. International Wound Journal. 13(2). 268–271. 11 indexed citations
17.
Zhang, Shengmin, et al.. (2013). Novel alternative therapy for spinal tuberculosis during surgery: reconstructing with anti-tuberculosis bioactivity implants. Expert Opinion on Drug Delivery. 11(3). 299–305. 24 indexed citations
18.
Du, Yingying, et al.. (2013). Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis. Biomedical Reports. 1(2). 269–274. 4 indexed citations
19.
Du, Yingying, et al.. (2012). Synergistic Effects of Exemestane and Aspirin on MCF-7 Human Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 13(11). 5903–5908. 18 indexed citations
20.
Wu, Hongyang, Zhendong Chen, Guoping Sun, et al.. (2009). Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain. Journal of Experimental & Clinical Cancer Research. 28(1). 33–33. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ye Yuan Breakdown of academic impact, for papers by Lu Ma Breakdown of academic impact, for papers by Wei Ma Breakdown of academic impact, for papers by Changhong Zhu Breakdown of academic impact, for papers by Rong Wei Breakdown of academic impact, for papers by Yuanhua Liu Breakdown of academic impact, for papers by Bolan Yu Breakdown of academic impact, for papers by Jianbo Li Breakdown of academic impact, for papers by Xiuhong Zhang
Rankless by CCL
2026